Skip to main content

Advertisement

SpringerLink
Log in

Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells

  • Short Communication
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Glioblastoma multiforme is still a tumor with very poor prognosis. Statins are actually used for the treatment of dyslipidemias and thiazolidinediones for improving insulin sensitivity in diabetes. Statins are inhibitors of the cholesterol pathway, while thiazolidinediones are peroxisomal proliferator activator receptor γ (PPAR) agonists. For both, a potent pro-apoptotic activity has been suggested.

Methods

We compared the antiglioma effect of simvastatin, atorvastatin, lovastatin, pravastatin, rosuvastatin, rosiglitazone, pioglitazone and their combinations at several concentrations on human glioblastoma cell lines U87, U 138, LN 405 and rat RG II. The cytotoxic effect was assessed using a cell proliferation assay after 48 and 144 h. Caspase 3 activity and the addition of isoprenoids and PPAR-y inhibitor GW9662 were assessed. Experiments were as well conducted under hypoxia for 24 h.

Results

We demonstrated a significant cytotoxic effect with a combination of statins plus pioglitazone. The effect was observed after 48 h and dramatically increased after 144 h. The combination of 2 types of statins (synthetic and natural) allowed a fivefold dose reduction. Statin effect was reversed with isoprenoids and partially with PPAR-γ antagonists, while thiazolidinediones effect was slightly affected by PPAR-γ antagonists. A marked increase in caspase 3 activity was achieved by combining atorvastatin with lovastatin. Cytotoxicity of the combination of statins and thiazolidinediones did not decrease under hypoxia.

Conclusion

The assessed combination of statins with thiazolidinediones shows a synergistic cytotoxic effect against glioblastoma cells in vitro, which could represent a feasible therapeutic schema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5:2223

    PubMed  CAS  Google Scholar 

  2. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE et al (2006) Stroke prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355:549

    Article  PubMed  CAS  Google Scholar 

  3. Akasaki Y, Liu G, Matundan HH, Ng H, Yuan X, Zeng Z, Black KL, Yu JS (2006) A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. J Biol Chem 281:6165

    Article  PubMed  CAS  Google Scholar 

  4. Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC (2000) Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res 20:2761

    PubMed  CAS  Google Scholar 

  5. Cafforio P, Dammacco F, Gernone A, Silvetris F (2005) Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 26:883

    Article  PubMed  CAS  Google Scholar 

  6. Cemeus C, Zhao TT, Barrett GM, Lorimer IA, Dimitroulakos J (2008) Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status. J Neurooncol 90:9

    Article  PubMed  CAS  Google Scholar 

  7. Chan DY, Chen GG, Poon WS, Liu PC (2008) Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis. J Neurooncol 86:273

    Article  PubMed  CAS  Google Scholar 

  8. Coras R, Hölsken A, Seufert S, Hauke J, Eyüpoglu IY, Reichel M et al (2007) The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion. Mol Cancer Ther 6:1745

    Article  PubMed  CAS  Google Scholar 

  9. Demetri GD, Fletcher CD, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM, Singer S (1999) Induction of solid tumor differentiation by the peroxisome proliferator activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96:3951

    Article  PubMed  CAS  Google Scholar 

  10. Dimitroulakos J, Thai S, Wasfy GH, Hedley DW, Minden MD, Penn LZ (2000) Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma 40:167

    Article  PubMed  CAS  Google Scholar 

  11. Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ (2001) Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin induced apoptosis: therapeutic implications. Clin Cancer Res 7:158

    PubMed  CAS  Google Scholar 

  12. Fletcher B, Berra K, Ades P, Braun LT, Burke LE, Durstine JL et al (2005) Managing abnormal blood lipids: a collaborative approach. Circulation 112:3184

    Article  PubMed  Google Scholar 

  13. Gabryś D, Dörfler A, Yaromina A, Hessel F, Krause M, Oertel R, Baumann M (2008) Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo. Strahlenther Onkol 184:48

    Article  PubMed  Google Scholar 

  14. Gehring S, Tapia-Pérez JH, Kirches E, Firsching R, Keilhoff G, Schneider T, Mawrin C (2010) Cytotoxic effects of statins and thiazolidinediones on meningioma cells. J Neuro-oncol. doi:10.1007/s11060-010-0351-1

  15. Gliemroth J, Zulewski H, Arnold H, Terzis AJ (2003) Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin. Neurosurg Rev 26:117

    Article  PubMed  Google Scholar 

  16. Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT (2006) Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Mol Pharmacol 70:1524

    Article  PubMed  CAS  Google Scholar 

  17. Hindler K, Cleeland CS, Rivera E, Collard CD (2006) The role of statins in cancer therapy. Oncologist 11:306

    Article  PubMed  CAS  Google Scholar 

  18. Holstein SA, Knapp HR, Clamon GH, Murry DJ, Hohl RJ (2006) Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies. Cancer Chemother Pharmacol 57:155

    Article  PubMed  CAS  Google Scholar 

  19. Jensen R (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317

    Article  PubMed  CAS  Google Scholar 

  20. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM (2004) Lovastatin-induced up-regulation of the BH3-only protein, bim, and cell death in glioblastoma cells. J Neurochem 89:168

    Article  PubMed  CAS  Google Scholar 

  21. Jones KD, Couldwell WT, Hinton DR, Su Y, He S, Anker L, Law RE (1994) Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 205:1681

    Article  PubMed  CAS  Google Scholar 

  22. Kang DW, Choi CH, Park JY, Kang SK, Kim YK (2008) Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells. Neurochem Res 33:551

    Article  PubMed  CAS  Google Scholar 

  23. Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC (2009) Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets 13:701

    Article  PubMed  CAS  Google Scholar 

  24. Koyuturk M, Ersoz M, Altiok N (2004) Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase. Neurosci Lett 370:212

    Article  PubMed  CAS  Google Scholar 

  25. Larner J, Jane J, Laws E, Packer R, Myers C, Shaffrey M (1998) A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme. Am J Clin Oncol 21:579

    Article  PubMed  CAS  Google Scholar 

  26. Lichtor T, Glick RP (2003) Cytokine immuno-gene therapy for treatment of brain tumors. J Neuro Oncol 65:247

    Article  Google Scholar 

  27. Lichtor T, Spagnolo A, Glick RP, Feinstein DL (2008) PPAR-γ thiazolidinedione agonists and immunotherapy in the treatment of brain tumors. PPAR Res 2008:547470

    PubMed  Google Scholar 

  28. Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S (1997) Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 47:29

    PubMed  CAS  Google Scholar 

  29. Mason RP, Walter MF, Day CA, Jacob RF (2005) Intermolecular differences of 3-Hydroxy-3-Methylglutaryl coenzyme: a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol 96(suppl):11

    Article  Google Scholar 

  30. Masubuchi Y (2006) Metabolic and non metabolic factors determining troglitazone hepatotoxicity: A review. Drug Metab Pharmakokinet 21:347

    Article  CAS  Google Scholar 

  31. Minniti G, Muni R, Lanzetta G, Marchetti P, Enrici RM (2009) Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res 29:5171

    PubMed  CAS  Google Scholar 

  32. Nicholas MK (2007) Glioblastoma multiforme: evidence-based approach to therapy. Expert Rev Anticancer Ther 7(12 Suppl):S23

    Article  PubMed  CAS  Google Scholar 

  33. Obara S, Nakata M, Takeshima H, Kuratsu J, Maruyama I, Kitajima I (2002) Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK). Cancer Lett 185:153

    Article  PubMed  CAS  Google Scholar 

  34. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM, Halperin JA (2001) Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation. Cancer Res 61:6213

    PubMed  CAS  Google Scholar 

  35. Papi A, Tatenhorst L, Terwel D, Hermes M, Kummer MP, Orlandi M, Heneka MT (2009) PPAR gamma and RXR gamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models. Neurochem 109:1779

    Article  CAS  Google Scholar 

  36. Pérez-Ortiz JM, Tranque P, Burgos M, Vaquero CF, Llopis J (2007) Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide. Mol Pharmacol 72:407

    Article  PubMed  Google Scholar 

  37. Pichlmeier U, Bink A, Schakert G, Stummer W (2008) The ALA glioma study group resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025

    Article  PubMed  Google Scholar 

  38. Prasanna P, Thibault A, Liu L, Samid D (1996) Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells. J Neurochem 66:710

    Article  PubMed  CAS  Google Scholar 

  39. Schultze K, Böck B, Eckert A, Oevermann L, Ramacher D, Wiestler O, Roth W (2006) Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. Apoptosis 11:1503

    Article  PubMed  CAS  Google Scholar 

  40. Sironi L, Gianazza E, Gelosa P, Guerrini U, Nobili E, Gianella A, Cremonesi B, Paoletti R, Tremoli E (2005) Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol 25:598

    Article  PubMed  CAS  Google Scholar 

  41. Soma MR, Baetta R, Bergamaschi S, De Renzis MR, Davegna C, Battaini F, Fumagalli R, Govoni S (1994) PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment. Biochem Biophys Res Commun 200:1143

    Article  PubMed  CAS  Google Scholar 

  42. Soma MR, Baetta R, De Renzis MR, Azzini G, Davegna C, Butti G, Pezzotta S, Azzini G, Paoletti R, Fumagalli R (1995) In vivo enhanced antitumor activity of carmustine [N, N′-bis(2-chloroethyl)-N-nitrosourea] by simvastatin. Cancer Res 55:597

    PubMed  CAS  Google Scholar 

  43. Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P, Fumagalli R (1992) Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N, N′-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells. Cancer Res 52:4348

    PubMed  CAS  Google Scholar 

  44. Spagnolo A, Glick RP, Lin H, Cohen EP, Feinstein DL, Lichtor T (2007) Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts. J Neurosurg 106:299

    Article  PubMed  CAS  Google Scholar 

  45. Spagnolo A, Grant EN, Glick R, Lichtor T, Feinstein DL (2007) Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes. Neurosci Lett 417:72

    Article  PubMed  CAS  Google Scholar 

  46. Takahashi HK, Weitz-Schmidt G, Iwagaki H, Yoshino T, Tanaka N, Nishibori M (2006) Hypothesis: the antitumor activities of statins may be mediated by IL-18. J Leukoc Biol 80:215

    Article  PubMed  CAS  Google Scholar 

  47. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2:483

    PubMed  CAS  Google Scholar 

  48. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K et al (2007) Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 100:1442

    Article  PubMed  CAS  Google Scholar 

  49. Yao CJ, Lai GM, Chan CF, Cheng AL, Yang YY, Chuang SE (2006) Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone. Int J Cancer 118:773

    Article  PubMed  CAS  Google Scholar 

  50. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, Piser T (2003) 3-Hydroxy-3-Methyilglutaryl coenzyme. a reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23:1104

    Google Scholar 

  51. Zander T, Kraus JA, Grommes C, Schlegel U, Feinstein D, Klockgether T et al (2002) Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR gamma. J Neurochem 81:1052

    Article  PubMed  CAS  Google Scholar 

  52. Bababeygy SR, Polevaya NV, Youssef S, Sun A, Xiong A, Prugpichailers T, Veeravagu A, Hou LC, Steinman L, Tse V (2009) HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res 29:4901

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Ines Schellhase for her technical assistance in preparation of cell cultures. We thank AstraZeneca for the donation of the salt.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Otto von Guericke University Magdeburg, Magdeburg, Germany

    Jorge Humberto Tapia-Pérez, Raimund Firsching & Thomas Schneider

  2. Department of Neuropathology, Otto von Guericke University Magdeburg, Magdeburg, Germany

    Jorge Humberto Tapia-Pérez, Elmar Kirches & Christian Mawrin

  3. Klinik für Neurochirurgie, Otto-von-Guericke Universität Magdeburg, Leipziger Strasse 44, 39120, Magdeburg, Germany

    Jorge Humberto Tapia-Pérez

Authors
  1. Jorge Humberto Tapia-Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elmar Kirches
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Mawrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raimund Firsching
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Humberto Tapia-Pérez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tapia-Pérez, J.H., Kirches, E., Mawrin, C. et al. Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells. Cancer Chemother Pharmacol 67, 1193–1201 (2011). https://doi.org/10.1007/s00280-010-1535-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-010-1535-2

Keywords

Search

Navigation